rss
Mol Path 2002;55:102-109 doi:10.1136/mp.55.2.102
  • Original Article

Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo

  1. C L Chernicky,
  2. H Tan,
  3. L Yi,
  4. J R Loret de Mola,
  5. J Ilan
  1. Department of Reproductive Biology, Case Western Reserve University School of Medicine, Cleveland, OH 44106–4943, USA
  1. Correspondence to:
 Dr J Ilan, Department of Reproductive Biology, Case Western Reserve University, University MacDonald Women's Hospital, 11100 Euclid Avenue, Cleveland, OH 44106–4943, USA;
 cheryl.chernicky{at}uhhs.com

    Abstract

    Aims: To establish that cells from the murine mammary carcinoma cell line, EMT6, express type I insulin-like growth factor receptor (IGF-IR), tissue-type plasminogen activator (tPA), and urokinase-type plasminogen activator (uPA). To investigate the role of IGF-IR in growth, transformation, and tumorigenesis in addition to its relation to tPA and uPA in EMT6 cells. To assess the suitability of the EMT6/syngeneic mouse model for studying the role of IGF-IR in tumorigenesis.

    Methods: The presence of transcripts for IGF-IR, tPA, and uPA was determined by northern blot analysis using poly (A+) RNA derived from EMT6 cells transfected with an antisense IGF-IR construct or a construct lacking the antisense IGF-IR insert. Flow cytometry was used to measure IGF-IR protein. Assays were performed to determine cell proliferation, transformation, and the tumorigenicity of antisense IGF-IR transfected EMT6 cells and control transfected EMT6 cells.

    Results: There was strong expression of IGF-IR, tPA, and uPA in EMT6 cells. EMT6 cells from clones carrying antisense IGF-IR displayed a significant decrease in cell proliferation and lost the ability to form colonies in soft agar. A decrease in tumour size occurred when cells carrying the antisense IGF-IR were injected into syngeneic mice. Reduced expression of tPA and uPA was seen in EMT6 cells carrying the antisense IGF-IR construct.

    Conclusions: The IGF-IR plays a role in the progression, transformation, and tumorigenesis of EMT6 murine mammary carcinoma cells. The suppression of IGF-IR mRNA in EMT6 cells decreases tPA and uPA expression. EMT6 cells and the syngeneic mouse provide a suitable model for studying the role of IGF-IR in breast tumour progression.